Please login to the form below

Not currently logged in
Email:
Password:

Melior enters new pharmaceutical collaboration

Melior Discovery signs an agreement with Johnson & Johnson Pharmaceutical Research & Development for use of Melior's proprietary theraTRACE indications discovery platform to identify new indications

US-based drug discovery company Melior Discovery has signed an agreement with Johnson & Johnson Pharmaceutical Research & Development (J&JPRD) for use of Melior's proprietary theraTRACE indications discovery platform to identify new indications for multiple J&JPRD drug candidates.

Financial terms were not disclosed.

Melior's theraTRACE platform is a multiplexed set of integrated in-vivo models which quickly identify previously unknown applications for pharmaceutical compounds. It can be applied to discovery, development stage and marketed agents and has already identified novel indications for a number of development stage drugs.

Dr Andrew Reaume, president and CEO of Melior, said of the agreement: "Our theraTRACE indications discovery platform is already proving its value in our existing collaborations with Merck and Pfizer, as well as in screening for our own drug development efforts. We are delighted to be working with J&JPRD, and we look forward to a productive collaboration."

7th August 2007

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Healthcircle

We're Healthcircle – an award-winning healthcare advertising and creative communications agency, offering a holistic approach to brand health. With a...

Latest intelligence

Digital applications are transforming the market access landscape
Organisations are leveraging new technology to implement a wider range of business models and, in essence, drive market access success by working smarter, faster and with greater economy....
Escaping the spin cycle of sub-optimal launch
...
NHS Long Term Plan - Digital is firmly on the agenda. Are you ready?
The message is clear. To keep pace with the NHS, pharma and healthcare companies must act now and refine their digital strategy to meet the needs of a transforming NHS....

Infographics